New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Patented technology uses curcumin for potent inhibitory effects on the development of food allergy

Patented technology uses curcumin for potent inhibitory effects on the development of food allergy

by Anna Zarra Aldrich,University of ConnecticutClinton Mathias in his UConn lab. Credit: Jason Sheldon / UConnClinton Mathias, associate professor of nutritional sciences in the College of Agric
Immunology & Rheumatology June 15,2024
Patented technology uses curcumin for potent inhibitory effects on the development of food allergy

Patented technology uses curcumin for potent inhibitory effects on the development of food allergy

by Anna Zarra Aldrich,University of ConnecticutClinton Mathias in his UConn lab. Credit: Jason Sheldon / UConnClinton Mathias, associate professor of nutritional sciences in the College of Agric
Immunology & Rheumatology June 15,2024
Putting the brakes on chronic inflammation: Study discovers link between two key pathways

Putting the brakes on chronic inflammation: Study discovers link between two key pathways

by Weill Cornell Medical CollegeA single-cell atlas of IL-23 responses in the small intestine identifies CTLA-4+ILC3s. Credit:Nature(2024). DOI: 10.1038/s41586-024-07537-3Scient
Breakthroughs June 15,2024
Putting the brakes on chronic inflammation: Study discovers link between two key pathways

Putting the brakes on chronic inflammation: Study discovers link between two key pathways

by Weill Cornell Medical CollegeA single-cell atlas of IL-23 responses in the small intestine identifies CTLA-4+ILC3s. Credit:Nature(2024). DOI: 10.1038/s41586-024-07537-3Scient
Breakthroughs June 15,2024
Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

by Science China PressLoss of primary cilia results in the downregulation of PD-L1 expression, which contributes to unrestrained local T cell proliferation and activation. Credit: Science China P
Immunology & Rheumatology June 15,2024
Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

Study finds primary cilia restrict autoinflammation by mediating PD-L1 expression

by Science China PressLoss of primary cilia results in the downregulation of PD-L1 expression, which contributes to unrestrained local T cell proliferation and activation. Credit: Science China P
Immunology & Rheumatology June 15,2024
Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients

Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients

by Elana GotkineThere is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a histo
Immunology & Rheumatology June 15,2024
Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients

Study finds no link between exposure to immunosuppressive therapy, cancer in IBD patients

by Elana GotkineThere is no significant association between exposure to immunosuppressive therapies and development of incident cancers among patients with inflammatory bowel disease (IBD) and a histo
Immunology & Rheumatology June 15,2024
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan

Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan

by St. Jude Children's Research HospitalCartoon summary of experiential age-associated DNA methylation programs that delineate longevity versus malignancy among T cells. Credit:Nature A
Geriatrics June 15,2024
Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan

Age is just a number: Immune cell 'epigenetic clock' ticks independently of organism lifespan

by St. Jude Children's Research HospitalCartoon summary of experiential age-associated DNA methylation programs that delineate longevity versus malignancy among T cells. Credit:Nature A
Geriatrics June 15,2024
Boosting CAR-T cell therapies from under the skin

Boosting CAR-T cell therapies from under the skin

by Benjamin Boettner,Harvard UniversityT-cell enhancing scaffolds can be locally injected under the skin following CAR-T cell therapy, and allowcirculating CAR-T cells to infiltrate their 3-dime
Immunology & Rheumatology June 15,2024
Boosting CAR-T cell therapies from under the skin

Boosting CAR-T cell therapies from under the skin

by Benjamin Boettner,Harvard UniversityT-cell enhancing scaffolds can be locally injected under the skin following CAR-T cell therapy, and allowcirculating CAR-T cells to infiltrate their 3-dime
Immunology & Rheumatology June 15,2024
Suppressing graft-versus-host disease using immunosuppressive iPS cell-derived regulatory T cells

Suppressing graft-versus-host disease using immunosuppressive iPS cell-derived regulatory T cells

by Kyoto UniversityGraphical abstract. Credit:Cell Stem Cell(2024). DOI: 10.1016/j.stem.2024.05.004A recent study by a team led by Professor Shin Kaneko successfully induced regulator
Immunology & Rheumatology June 15,2024
Suppressing graft-versus-host disease using immunosuppressive iPS cell-derived regulatory T cells

Suppressing graft-versus-host disease using immunosuppressive iPS cell-derived regulatory T cells

by Kyoto UniversityGraphical abstract. Credit:Cell Stem Cell(2024). DOI: 10.1016/j.stem.2024.05.004A recent study by a team led by Professor Shin Kaneko successfully induced regulator
Immunology & Rheumatology June 15,2024
Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19

Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19

by George Washington UniversityCredit: Pixabay/CC0 Public DomainBy late in the pandemic, more than 96% of individuals in the U.S. ages 16 and older had COVID-19 antibodies from infection or vacci
Immunology & Rheumatology June 15,2024
Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19

Convenient at-home test identifies at-risk individuals with inadequate immunity to COVID-19

by George Washington UniversityCredit: Pixabay/CC0 Public DomainBy late in the pandemic, more than 96% of individuals in the U.S. ages 16 and older had COVID-19 antibodies from infection or vacci
Immunology & Rheumatology June 15,2024
Position paper examines safety of receiving live vaccines while on dupilumab

Position paper examines safety of receiving live vaccines while on dupilumab

by American College of Allergy, Asthma, and ImmunologyCredit: CC0 Public DomainA new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of a
Immunology & Rheumatology June 15,2024
Position paper examines safety of receiving live vaccines while on dupilumab

Position paper examines safety of receiving live vaccines while on dupilumab

by American College of Allergy, Asthma, and ImmunologyCredit: CC0 Public DomainA new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of a
Immunology & Rheumatology June 15,2024
Study shows magnesium sulfate reduces risk of cerebral palsy and death for very preterm babies

Study shows magnesium sulfate reduces risk of cerebral palsy and death for very preterm babies

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Kristina Paukshtite from PexelsAn international research collaboration conducting a comprehensive review of studies from acros
OB & GYN June 15,2024
Study shows magnesium sulfate reduces risk of cerebral palsy and death for very preterm babies

Study shows magnesium sulfate reduces risk of cerebral palsy and death for very preterm babies

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Kristina Paukshtite from PexelsAn international research collaboration conducting a comprehensive review of studies from acros
OB & GYN June 15,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com